Novartis

glue scissors art supplies

Biotech

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Novartis stuck a second deal with Orionis, this time handing $40 million to the molecular glue biotech to work on “challenging therapeutic targets.”

James Waldron Jun 10, 2026 8:21am

Berlin Germany Brandenburg Gate

Fierce Pharma

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm

Brain scan neuroscience

Novartis ‘always looking’ for new ways to shuttle drugs to brain

May 28, 2026 8:44am

Novartis booth at AACR 2026

Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?

May 22, 2026 8:28am

NVS

Novartis trims ‘select number’ of biomedical research roles

May 15, 2026 10:58am

Narasimhan

Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts

Apr 28, 2026 3:21am